Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06853899 · ClinicalTrials.gov registry record · NA

Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health

A NA study of Skin Aging and Skin Hydration, sponsored by Truology.

Completed
Registry status
NA
Development phase
33
Enrollment target
1
Study location

NCT06853899 is a NA study of Skin Aging and Skin Hydration that has completed, run by Truology. The registered enrollment target is 33 participants, below the 72-participant average among 9 other Skin Aging trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06853899, a NA study of Skin Aging and Skin Hydration, has completed, sponsored by Truology.

COMPLETED
Registry status
NA
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

This clinical trial evaluates the efficacy of three skincare products-Truology A2 (0.2% Retinaldehyde Serum), Truology C-Boost, and Truology Barrier Restore-in improving skin quality and health. The study will assess improvements in skin firmness, evenness, brightness, hydration, fine lines/wrinkles, redness, and skin stress/irritation.

Interventions

  • DIETARY_SUPPLEMENT Truology A2
  • DIETARY_SUPPLEMENT Truology C-Boost
  • DIETARY_SUPPLEMENT Truology Barrier Restore

Study Locations (1)

Nevada

  • Citruslabs - Las Vegas

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2024-10-21
Est. Completion 2025-01-10
Phase NA

Sponsor

Truology

1 total trials

What the Registry Record Tells You About NCT06853899

The ClinicalTrials.gov registry entry for NCT06853899 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 72-participant average among 9 other Skin Aging trials with a reported enrollment target (54% lower). The listed sponsor is Truology, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Skin Aging appearing as the primary indexed condition, and to 3 interventions - of which Truology A2 is the first listed.

NCT06853899 reports 1 study location spanning 1 distinct geographic area - top geographies include Nevada.

Frequently Asked Questions

What is clinical trial NCT06853899 about?

NCT06853899 is a clinical study titled "Clinical Trial to Evaluate the Efficacy of Skin Products to Improve Skin Quality and Health". This clinical trial evaluates the efficacy of three skincare products-Truology A2 (0.2% Retinaldehyde Serum), Truology C-Boost, and Truology Barrier Restore-in improving skin quality and health. The study will assess improvements in skin firmness, evenness, brightness, hydration, fine lines/wrinkles...

What is the current status of trial NCT06853899?

This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2024-10-21. Estimated completion is 2025-01-10.

What conditions does trial NCT06853899 study?

This clinical trial studies the following conditions: Skin Aging, Skin Hydration.

What interventions are being tested in trial NCT06853899?

The interventions under investigation include: Truology A2 (DIETARY_SUPPLEMENT), Truology C-Boost (DIETARY_SUPPLEMENT), Truology Barrier Restore (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06853899?

This trial is sponsored by Truology, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06853899 being conducted?

This trial has 1 study location across Nevada. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.